K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 | PFIZER INC.PFE | 47 | $46.8M |
| 2 | GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 | META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 | AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 | LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 | FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 | ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 | ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 | AMGEN INCAMGN | 19 | $24.9M |
| 11 | COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 | MERCK & CO INCMRK | 14 | $24.0M |
| 13 | SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 | GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 | APPLE INCAAPL | 9 | $22.1M |
| 16 | T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 | UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 | VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 | OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 | MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 | QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 | GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 | BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 | ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | METAMeta Platforms Inc. | 129 | $50.2M |
| 2 | PFEPfizer Inc. | 87 | $48.6M |
| 3 | GMGeneral Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZNAmazon.com Inc. | 80 | $35.3M |
| 6 | LMTLockheed Martin Corporation | 88 | $29.4M |
| 7 | FDXFedEx Corporation | 82 | $28.3M |
| 8 | LLYEli Lilly and Company | 83 | $28.1M |
| 9 | AMGNAmgen Inc. | 95 | $28.0M |
| 10 | MRKMerck & Co. Inc. | 92 | $27.5M |
| 11 | AAPLApple Inc. | 64 | $26.8M |
| 12 | GOOGLAlphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SOSouthern Company | 108 | $26.1M |
| 15 | UNHUnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZVerizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 | CHTR | 137 | $22.6M |
| 19 | GDGeneral Dynamics Corporation | 127 | $22.5M |
| 20 | TAT&T Inc. | 134 | $21.6M |
| 21 | ORCLOracle Corporation | 132 | $20.6M |
| 22 | CMCSAComcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXYOccidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFTMicrosoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · DEXCOM INC.
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-20 | DXCM | DEXCOM INC. | DEXCOM, INC. | $380K | CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology Issues related to CY 2026 rulemaking CGM Coverage policies Issues related to breakthrough technology Issues related to global supply chains Issues related to the Administration's Executive Orders |
| 2026-04-20 | DXCM | DEXCOM INC. | FARRAGUT PARTNERS LLP | $50K | General representation. Legislative and regulatory issues related to policies and payments for continuous glucose monitoring |
| 2026-04-20 | DXCM | DEXCOM INC. | ALSTON & BIRD LLP | $40K | Issues related to coverage and reimbursement for continuous glucose monitors. Issues related to coverage and reimbursement for continuous glucose monitors. |
| 2026-01-20 | DXCM | DEXCOM INC. | DEXCOM, INC. | $390K | Issues related to global supply chains Issues related to the Administration's Executive Orders CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology Issues related to CY 2026 rulemaking CGM Coverage policies Issues related to breakthrough technology |
| 2026-01-20 | DXCM | DEXCOM INC. | FARRAGUT PARTNERS LLP | $50K | General representation. Legislative and regulatory issues related to policies and payments for continuous glucose monitoring |
| 2026-01-20 | DXCM | DEXCOM INC. | ALSTON & BIRD LLP | $40K | Issues related to coverage and reimbursement for continuous glucose monitors. Issues related to coverage and reimbursement for continuous glucose monitors. |
| 2025-10-20 | DXCM | DEXCOM INC. | DEXCOM, INC. | $370K | CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology CGM Coverage policies Issues related to breakthrough technology Issues related to global supply chains Issues related to the Administration's Executive Orders |
| 2025-10-20 | DXCM | DEXCOM INC. | ALSTON & BIRD LLP | $50K | Issues related to coverage and reimbursement for continuous glucose monitors. Issues related to coverage and reimbursement for continuous glucose monitors. |
| 2025-10-20 | DXCM | DEXCOM INC. | FARRAGUT PARTNERS LLP | $50K | General representation. Legislative and regulatory issues related to policies and payments for continuous glucose monitoring |
| 2025-07-21 | DXCM | DEXCOM INC. | DEXCOM, INC. | $290K | CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology CGM Coverage policies Issues related to breakthrough technology Issues related to global supply chains Issues related to the Administration's Executive Orders |
| 2025-07-21 | DXCM | DEXCOM INC. | FARRAGUT PARTNERS LLP | $50K | General representation. Legislative and regulatory issues related to policies and payments for continuous glucose monitoring |
| 2025-07-21 | DXCM | DEXCOM INC. | ALSTON & BIRD LLP | $50K | Issues related to coverage and reimbursement for continuous glucose monitors. Issues related to coverage and reimbursement for continuous glucose monitors. |
| 2025-04-21 | DXCM | DEXCOM INC. | DEXCOM, INC. | $270K | CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology CGM Coverage policies Issues related to breakthrough technology Issues related to global supply chains Issues related to the Administrations Executive Orders |
| 2025-04-21 | DXCM | DEXCOM INC. | FARRAGUT PARTNERS LLP | $50K | General representation. Legislative and regulatory issues related to policies and payments for continuous glucose monitoring |
| 2025-04-21 | DXCM | DEXCOM INC. | ALSTON & BIRD LLP | $50K | Issues related to coverage and reimbursement for continuous glucose monitor. Issues related to coverage and reimbursement for continuous glucose monitor. |
| 2025-01-21 | DXCM | DEXCOM INC. | DEXCOM, INC. | $260K | CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act Issues related to global supply chains |
| 2025-01-21 | DXCM | DEXCOM INC. | FARRAGUT PARTNERS LLP | $50K | General representation. Legislative and regulatory issues related to policies and payments for continuous glucose monitoring |
| 2025-01-21 | DXCM | DEXCOM INC. | ALSTON & BIRD LLP | $50K | Issues related to coverage and reimbursement for continuous glucose monitor. Issues related to coverage and reimbursement for continuous glucose monitor. |
PFIZER INC.
GENERAL MOTORS COMPANY
META PLATFORMS INC. AND VARIOUS SUBSIDIARIES
AMAZON.COM SERVICES LLC
LOCKHEED MARTIN CORPORATION
FEDEX CORPORATION
ELI LILLY AND COMPANY
ALTRIA CLIENT SERVICES LLC
AMGEN INC
COMCAST CORPORATION
MERCK & CO INC
SOUTHERN COMPANY
GOOGLE CLIENT SERVICES LLC
APPLE INC
T-MOBILE USA INC.
UNITEDHEALTH GROUP INC
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES
OCCIDENTAL PETROLEUM CORPORATION
MICROSOFT CORPORATION
QUALCOMM INCORPORATED
GENERAL DYNAMICS CORP
BOEING COMPANY
ORACLE CORPORATION
CHTR
T